Literature DB >> 8891604

Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.

V H Nguyen1, M Kassiou, G A Johnston, M J Christie.   

Abstract

Comparisons of binding parameters of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) at sigma binding sites in guinea pig and rat brain membranes demonstrated that [3H](+)-pentazocine binds to a single high-affinity site, whereas [3H]DTG binds to two high-affinity sites in both species. The Kd values of the radioligands were similar in both types of membranes. However, the density of sigma 1 sites in guinea pig was significantly higher than that of rat. Novel trishomocubanes were tested for their affinities at sigma 1 and sigma 2 binding sites in guinea pig brain membranes using [3H](+)-pentazocine and [3H]DTG as the radioligands. N-(4-Phenylbutyl)-3-hydroxy-4- azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane (ANSTO-14) showed the highest affinity for the sigma 1 site (Ki = 9.4 nM) and 19-fold sigma 1/sigma 2 selectivity, as a result of increasing the alkyl chain between the cubane moiety and the aromatic ring. N-(3'-Fluorophenyl)methyl- 3-hydroxy-4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11]dodeca ne (ANSTO-19), displayed the highest affinity for sigma 2 sites (Ki = 19.6 nM) and 8-fold sigma 2/sigma 1 selectivity due to a fluoro substitution in the meta position of the aromatic ring. These represent structurally novel lead compounds, especially for the development of selective sigma 2 receptor ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891604     DOI: 10.1016/0014-2999(96)00395-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

Review 1.  Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs?

Authors:  Cornelis J Van der Schyf; Werner J Geldenhuys
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 2.  Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo.

Authors:  Robert Henry Mach; Kenneth Theodore Wheeler
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2009-09

3.  Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Authors:  Yuko Yasui; Tsung-Ping Su
Journal:  J Drug Alcohol Res       Date:  2016-02-20

4.  Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats.

Authors:  Takato Hiranita; Paul L Soto; Gianluigi Tanda; Theresa A Kopajtic; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2013-08-01       Impact factor: 4.030

5.  Evidence for sigma-1-like receptors in isolated rat liver mitochondrial membranes.

Authors:  Anis Klouz; Rosa Sapena; Jun Liu; Tangui Maurice; Jean-Paul Tillement; Vassilios Papadopoulos; Didier Morin
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  11-{[2-(3-Fluoro-phen-yl)eth-yl](meth-yl)amino}-penta-cyclo-[5.4.0.0.0.0]undecan-8-one.

Authors:  Samuel D Banister; Jack K Clegg; Raphy Hanani; Michael Kassiou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-30

7.  2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.

Authors:  Takato Hiranita; Derek S Wilkinson; Weimin C Hong; Mu-Fa Zou; Theresa A Kopajtic; Paul L Soto; Carl R Lupica; Amy H Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2014-02-11       Impact factor: 4.030

Review 8.  The σ2 receptor: a novel protein for the imaging and treatment of cancer.

Authors:  Robert H Mach; Chenbo Zeng; William G Hawkins
Journal:  J Med Chem       Date:  2013-06-18       Impact factor: 7.446

9.  2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations.

Authors:  Weimin C Hong; Theresa A Kopajtic; Lifen Xu; Stacey A Lomenzo; Bernandie Jean; Jeffry D Madura; Christopher K Surratt; Mark L Trudell; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2016-01-14       Impact factor: 4.030

Review 10.  Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives.

Authors:  Francesca Serena Abatematteo; Mauro Niso; Marialessandra Contino; Marcello Leopoldo; Carmen Abate
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.